Cited by 316Schizophrenia research and treatmentStress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities

Open access
Pruessner, Marita, Cullen, Alexis E., Aas, Monica, Walker, Elaine F.·2017·Neuroscience & Biobehavioral Reviews

Abstract

Over the past decade, our understanding of the role of stress in serious mental illness has become more sophisticated. In this paper, we revisit the neural diathesis-stress model of schizophrenia that was initially proposed in 1997 and updated in 2008. In light of cumulative research findings, we must now encompass evidence on the premorbid periods of psychosis, and our more nuanced understanding of hypothalamic-pituitary-adrenal (HPA) axis function and its association with neurodevelopmental, epigenetic, neurotransmitter, and inflammatory processes, as well as brain structure and function. Giving consideration to the methodological complexities that have become more apparent as research in this area has burgeoned, the various indices of HPA axis function, and the different stages of illness, we review relevant research published since the 2008 update of the model. We conclude by proposing an extended neural diathesis-stress model that addresses the broader neurobiological context of stress psychobiology in psychosis progression. Implications of this model for best practice, with regards to both future research and treatment strategies, are discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2016.12.013

Cites

396 of 396 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 398 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Howes O, McCutcheon R , Stone J (2015). Glutamate and dopamine in schizophrenia: an update for the 21st century. Journal of psychopharmacology 29, 97-115.
  2. Rogosa D (1995). Myths and methods: "Myths about longitudinal research," plus supplemental questions. In The analysis of change (ed. E. J. M. Gottman), pp. 3-65. Lawrence Erlbaum Associates: Hillsdale, New Jersey.

Cited by

Sorted by citations

Authors
Pruessner, M., Cullen, A. E., Aas, M., & Walker, E. F.
Affiliations
  • Douglas Mental Health University Institute (CA)
  • King's College London (GB)
  • University of Oslo (NO)
  • Emory University (US)
Corresponding author
Pruessner, Marita
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2017-02
Volume
73
Pages
191-218
ISSN
0149-7634 (ISSN-L)
OpenAlex
W2562716042
Cited by
315
References
398
Citations by year
2026: 17 · 2025: 37 · 2024: 33 · 2023: 53 · 2022: 34 · 2021: 32 · 2020: 35 · 2019: 35 · 2018: 26 · 2017: 13
FWCI
3.53
Type
journal article
Language
en
Open access
Locations
  • Neuroscience & Biobehavioral Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
  • National Institutes of Mental Health (UO1MH081988)
  • Golden Family foundation, and Canadian Institutes of Health Research (CIHR125913)
  • Sir Henry Wellcome Postdoctoral Fellowship (107395/Z/15/Z)
  • Waterloo Foundation Child Development (164/1719)
  • University of Oslo (#2013088)
  • NARSAD Young Investigator (22388)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
schizophrenia, hypothalamic-pituitary-adrenal axis, disease stage, brain development, epigenetics, neurotransmitters, neuroinflammation, brain structure and function
MeSH terms
Disease Susceptibility, Humans, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Psychotic Disorders, Schizophrenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review